🇯🇵 Japan: new Japanese Standards of Quasi-drug Ingredients 2021 become mandatory
30 Sep · Japan · Confidence: Secondary (authoritative)
What happens
The revision of 21 March 2025 amended 15 general test methods and 222 ingredient specifications. From 30 September 2026, the new specifications apply unless a minor change notification allowing continued use of the old specifications was filed before September.
What to do
Companies manufacturing or selling quasi-drugs (medicated cosmetics) for Japan should review their raw material specifications.
Source
Pharmaceutical Affairs Notice No. 0321-1 (March 21, 2025) · A related notice was also issued on the same day: Drug Administration and Review Notice No. 0321-1
Pick your category — get recalls & regulation alerts weekly
Leave your email and the category you make: each week we tell you what was recalled or noticed in the EU and US, which deadlines are close, and who just raised money. Or use RSS. Free; unsubscribe anytime.
- EU recalls and US Prop 65 notices in your category
- Upcoming regulatory deadlines
- Opportunities filtered for your role